J1956
J1956 – Injection, levofloxacin, 250 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 28 NDCs crosswalked per 250 MG $1.909/unit ASP+6%
📋 J1956 summary
J1956 is a HCPCS Level II J-code used to bill levofloxacin, 250 mg, billed per 250 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1956: Levofloxacin-D5W, Levofloxacin
Code J1956
Billing unit 250 MG Payment limit $1.909/unit NDC-Crosswalk 28
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1956
DescriptorInjection, levofloxacin, 250 mg
Billing unit250 MG
Payment limit / unit$1.909
Est. ASP / unit$1.801 est.
Mapped NDCs28
Data periodQ3 2026
Last updated2026-09-20
💊 About Levofloxacin Injection DRUG GUIDE
Levofloxacin in 5% Dextrose Injection treats mild, moderate and severe infections in adults (18 and older) caused by bacteria that are susceptible to it.
It is used when giving the medicine through a vein is advantageous, for example when a person cannot tolerate an oral form.Uses include pneumonia (hospital-acquired and community-acquired), skin infections, chronic bacterial prostatitis, urinary tract infections, acute pyelonephritis (kidney infection), acute bacterial exacerbation of chronic bronchitis, and acute bacterial sinusitis.
It is also used after exposure to inhalational anthrax and for plague, including in children 6 months and older for those two uses.
Clinical overview from our editorial drug guide for Levofloxacin Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.909
Est. ASP / unit
$1.801 est.
Est. after 2% sequester
$1.871
HCPCS dosage
250 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, levofloxacin, 250 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date1999-01-01
Date added1999-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1956 = 250 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1956 WITH EST. MEDICARE PAY
28 NDCs map to J1956. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.909/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9315-24 | Levofloxacin 250 mg/50mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9315-24) / 50 mL... | 250 mg/50mL | 24 | $45.82 | — | ● Active | CMS + PDAC |
| 00143-9316-24 | Levofloxacin 500 mg/100mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9316-24) / 100 m... | 500 mg/100mL | 48 | $91.63 | — | ● Active | CMS + PDAC |
| 00143-9317-24 | Levofloxacin 750 mg/150mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9317-24) / 150 m... | 750 mg/150mL | 72 | $137.45 | — | ● Active | CMS + PDAC |
| 00143-9720-24 | Levofloxacin 750 mg/150mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9720-24) / 150 m... | 750 mg/150mL | 72 | $137.45 | — | ● Active | CMS ASP |
| 00143-9721-24 | Levofloxacin 500 mg/100mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9721-24) / 100 m... | 500 mg/100mL | 48 | $91.63 | — | ● Active | CMS ASP |
| 00143-9722-24 | Levofloxacin 250 mg/50mL INJECTION, SOLUTION | Hikma | 24 BAG in 1 CARTON (0143-9722-24) / 50 mL... | 250 mg/50mL | 24 | $45.82 | — | ● Active | CMS ASP |
| 00409-2220-24 | Levofloxacin 250 mg/50mL INJECTION, SOLUTION | Hospira, | 24 POUCH in 1 CARTON (0409-2220-24) / 1 B... | 250 mg/50mL | 24 | $45.82 | — | ● Active | CMS + PDAC |
| 00409-3330-24 | Levofloxacin 500 mg/100mL INJECTION, SOLUTION | Hospira, | 24 POUCH in 1 CARTON (0409-3330-24) / 1 B... | 500 mg/100mL | 48 | $91.63 | — | ● Active | CMS + PDAC |
| 00409-4444-24 | Levofloxacin 750 mg/150mL INJECTION, SOLUTION | Hospira, | 24 POUCH in 1 CARTON (0409-4444-24) / 1 B... | 750 mg/150mL | 72 | $137.45 | — | ● Active | CMS + PDAC |
| 25021-0132-81 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | Sagent | 24 POUCH in 1 CARTON (25021-132-81) / 1 B... | 5 mg/mL | 24 | $45.82 | — | ● Active | CMS ASP |
| 25021-0132-82 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | Sagent | 24 POUCH in 1 CARTON (25021-132-82) / 1 B... | 5 mg/mL | 48 | $91.63 | — | ● Active | CMS ASP |
| 25021-0132-83 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | Sagent | 24 POUCH in 1 CARTON (25021-132-83) / 1 B... | 5 mg/mL | 72 | $137.45 | — | ● Active | CMS ASP |
| 44567-0435-24 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | WG | 24 POUCH in 1 CARTON (44567-435-24) / 1 B... | 5 mg/mL | 24 | $45.82 | — | ● Active | CMS + PDAC |
| 44567-0436-24 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | WG | 24 POUCH in 1 CARTON (44567-436-24) / 1 B... | 5 mg/mL | 48 | $91.63 | — | ● Active | CMS + PDAC |
| 44567-0437-24 | Levofloxacin 5 mg/mL INJECTION, SOLUTION | WG | 24 POUCH in 1 CARTON (44567-437-24) / 1 B... | 5 mg/mL | 72 | $137.45 | — | ● Active | CMS + PDAC |
| 63323-0355-50 | Levofloxacin 5 mg/mL INJECTION | Fresenius | 1 BAG in 1 POUCH (63323-355-50) / 50 mL i... | 5 mg/mL | 24 | $45.82 | — | ● Active | CMS ASP |
| 00409-0528-35 | LEVOFLOXACIN IN 5% DEXTROSE (24X150ML, SINGLE-USE,PF) 5%-750 MG/150 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
| 00409-0528-25 | LEVOFLOXACIN IN 5% DEXTROSE (24X100ML, SINGLE-USE,PF) 5%-500 MG/100 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
| 00409-0528-15 | LEVOFLOXACIN IN 5% DEXTROSE (24X50ML, SINGLE-USE,PF) 5%-250 MG/50 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
| 55150-0245-52 | Levofloxacin 750 mg/150mL INJECTION, SOLUTION | Eugia | 24 POUCH in 1 CARTON (55150-245-52) / 1 B... | 750 mg/150mL | 0.02 | $0.04 | — | ● Active | PDAC |
| 55150-0244-47 | Levofloxacin 500 mg/100mL INJECTION, SOLUTION | Eugia | 24 POUCH in 1 CARTON (55150-244-47) / 1 B... | 500 mg/100mL | 0.02 | $0.04 | — | ● Active | PDAC |
| 55150-0243-46 | Levofloxacin 250 mg/50mL INJECTION, SOLUTION | Eugia | 24 POUCH in 1 CARTON (55150-243-46) / 1 B... | 250 mg/50mL | 0.02 | $0.04 | — | ● Active | PDAC |
| 62991-2707-03 | LEVOFLOXACIN | Unknown | — | — | 4 | $7.64 | — | — | PDAC |
| 62991-2707-02 | Levofloxacin Hemihydrate 1 g/g POWDER | LETCO | 100 g in 1 JAR (62991-2707-2) | 1 g/g | 4 | $7.64 | — | ● Active | PDAC |
| 38779-2363-05 | LEVOFLOXACIN HEMIHYDRATE (1X100GM) | Unknown | — | — | 4 | $7.64 | — | — | PDAC |
| 36000-0296-24 | PREMIERPRO RX LEVOFLOXACIN IN 5% DEXTROSE (PF,LATEX-FREE) 5%-750 MG/150 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
| 36000-0295-24 | PREMIERPRO RX LEVOFLOXACIN IN 5% DEXTROSE (PF,LATEX-FREE) 5%-500 MG/100 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
| 36000-0294-24 | PREMIERPRO RX LEVOFLOXACIN IN 5% DEXTROSE (PF,LATEX-FREE) 5%-250 MG/50 ML | Unknown | — | — | 0.02 | $0.04 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$2.9K
Claims
524
Beneficiaries
167
Spend / beneficiary
$17.41
Spend / claim
$5.55
Trend by period
Where J1956 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #732 of 824
#727
TESTOSTERONE ENANTHA... J3121
$3.1K
#728
DOPAMINE HCL IN 5% D... J1265
$3.1K
#729
HALDOL DECANOATE 100... J1631
$3.1K
#730
GEMCITABINE HCL(J919... J9196
$3K
#731
PAMIDRONATE DISODIUM J2430
$3K
#732
LEVOFLOXACIN-D5W J1956
$2.9K
#733
CLEOCIN PHOSPHATE* J0736
$2.8K
#734
MANNITOL(J2151) J2151
$2.8K
#735
CHLOROTHIAZIDE SODIU... J1205
$2.7K
#736
AZMIRO J1072
$2.7K
#737
DIPYRIDAMOLE J1245
$2.6K
Total claims — #449 of 824
#444
TOPOTECAN HCL J9351
553
#445
CINQAIR J2786
540
#446
DACARBAZINE J9130
534
#447
BUMETANIDE J1939
532
#448
LYUMJEV J1813
526
#449
LEVOFLOXACIN-D5W J1956
524
#450
RISPERDAL CONSTA* J2794
517
#451
ALBUMIN (HUMAN)* P9041
514
#452
BENDAMUSTINE HCL* J9033
507
#453
CEREZYME J1786
506
#454
IMLYGIC J9325
503
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $2.9K | 167 | 524 | $17.41 | $5.55 |
| 2025 (Q1-Q4) | $8.2K | 554 | 1,616 | $14.71 | $5.04 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$6.5K
Medicare paid
$5.4K
Submitted services
8,229
Denial rate
58.6%
Allowed / service
$1.90
Submitted charges
$95.2K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J1956 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 3,320 services across 8 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J1956
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-09-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
28 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1956 billing FAQ
What is HCPCS code J1956?
J1956 is a HCPCS Level II J-code used to bill Injection, levofloxacin, 250 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1956?
One unit of J1956 represents 250 MG. Report the number of units equal to the dose administered divided by 250 MG.
How many units of J1956 should I bill?
Divide the dose administered by the code's unit size (250 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1956?
The Medicare Part B payment limit is $1.909 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $1.871 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1956?
28 NDCs currently map to J1956 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1956 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.